Pore formation by the CDTb component of the Clostridioides difficile binary toxin is Ca2+-dependent
Year: 2025
Type: article
Abstract: Clostridioides difficile infection (CDI) is one of the five most urgent bacterial threats in the United States. Furthermore, hypervirulent CDI strains express a third toxin termed the C. difficile binary toxin (CDT), and its molecular mechanism for entering host cells is not fully elucidated. Like other AB-type binary toxins, CDT enters host cells via endosomes. Here we show via surface plasmon resonance and electrochemical impedance spectroscopy that the cell-binding component of CDT, termed CDTb, binds and form pores in lipid bilayers in the absence of its enzymatic component, CDTa. This occurs upon lowering free Ca2+ ion concentration, and not by decreasing pH, as found for other binary toxins (i.e., anthrax). Cryogenic electron microscopy (CryoEM), X-ray crystallography, and nuclear magnetic resonance (NMR) studies show that dissociation of Ca2+ from a single site in receptor binding domain 1 (RBD1) of CDTb triggers conformational exchange in CDTb. These and structure/function studies of a Ca2+-binding double mutant targeting RBD1 (i.e., D623A/D734A) support a model in which dissociation of Ca2+ from RBD1 induces dynamic properties in CDTb that enable it to bind and form pores in lipid bilayers. Calcium-dependent conformational exchange in the cell-binding component of the C. difficile binary toxin triggers its membrane insertion in contrast to other bacterial translocases that are pH sensitive.
Source: Communications Biology
Institutions: University of Maryland, Baltimore, Institute for Bioscience and Biotechnology Research, Merck & Co., Inc., Rahway, NJ, USA (United States), National Institute of Standards and Technology, The Graduate Center, CUNY, City College of New York, City University of New York, CUNY Advanced Science Research Center
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,190
Funders: National Institutes of Health, National Institute of Standards and Technology, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Center for Nanoscale Science and Technology
OpenAlex ID: W4411136992
